Drug Trial Radar · NCT06186037
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Last checked: Nov 20, 2026Latest source record: Jun 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
6,356
Planned (sponsor's estimate)
Start
Feb 1, 2024
Primary completion
Feb 28, 2029
Study completion Feb 28, 2029
Sponsor
- Lead sponsor
- Saint Vincent's Hospital, KoreaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 29, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
\[Purpose of the Clinical Study\]:The purpose of this study is to conduct a clinical comparison of low-dose rosuvastatin plus ezetimibe combination therapy and high-dose rosuvastatin monotherapy in patients with minimal to intermediate coronary artery disease without percutaneous coronary intervention to confirm non-inferiority in the reduction of key cardiovascular events. \[Hypothesis\]:In patients who have not undergone percutaneous coronary intervention for minimal to moderate coronary artery disease, low-dose rosuvastatin and ezetimibe combination therapy are non-inferior in terms of reducing major cardiovascular events compared to high-dose rosuvastatin monotherapy.
Conditions
- Coronary Artery Disease
- Dyslipidemias
- Primary Prevention
Interventions
Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mgDrug
Oral administration once a day, taking it for 3 years
Mono drug group of Rosuvastatin 20 mgDrug
Oral administration once a day, taking it for 3 years
Primary outcomes
What the sponsor says the trial is designed to measure.
- The occurrence rates of the compound variablesTime frame: Visit 5 (36month)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
St. Vincent's Hospital
Suwon, Gyeonggi-do, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.